AltraBio provides end-to-end medical data analysis and biostatistical support for clinical research, observational studies, and real-world evidence (RWE) projects. Operating across major therapeutic areas—including neurosciences, immunology, oncology, dermatology, cardiology, and rheumatology—our senior statisticians support human and veterinary biopharma, medical device manufacturers, biotechs, and academic medical centers from early design to post-market clinical follow-up.
End-to-End Biostatistical Services for Clinical Research
Study Design & Biostatistical Planning
Data Management & CDISC Compliance
Data Analysis, Modeling & Regulatory Valorization
Peer-Reviewed Clinical & Medical Publications
2024
BacSPaD: A Robust Bacterial Strains' Pathogenicity Resource Based on Integrated and Curated Genomic Metadata Journal Article
In: Pathogens, vol. 13, no. 8, 2024, ISSN: 2076-0817.
2023
In: Transfusion Clinique et Biologique, vol. 30, iss. S1, pp. S147, 2023.
P-CB-16 | Mathematical Models Can Predict Human Platelet Activity and Protein Expressions in Response to Various Stimulations Journal Article
In: Transfusion, vol. 63, iss. S5, pp. 156A-156A, 2023.
